Francis J. Alenghat

Francis Alenghat practices at The University of Chicago Medical Center in Chicago, Illinois.

Francis Alenghat's NPI, 1073633038, was assigned on March 30, 2007. Francis Alenghat graduated from Harvard Medical School in 2005. Francis Alenghat holds Illinois license 036133238.

Francis Alenghat's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Francis Alenghat's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Francis Alenghat is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Francis Alenghat to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Francis Alenghat practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Francis Alenghat's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Francis Alenghat is board certified in cardiovascular disease by the American Board of Internal Medicine. Francis Alenghat is licensed in Illinois.

CMS data shows 1,778 Medicare services from Francis Alenghat across 8 procedure codes in 2024, for 1,160 Medicare patients. Medicare paid $66,546 for them.

CMS counts 1,160 Medicare patients who saw Francis Alenghat in 2024. The largest group is 65 to 74, with 457 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Francis Alenghat's median patient age at 70, with 51% women.

In 2024, Francis Alenghat wrote 1,841 Medicare Part D claims for 334 patients. 85% of them were for generic drugs. CMS names the drug for 1,640 of them, across 29 drugs with 11 or more claims each, at $304,178 in total drug cost. In 2023, CMS named 1,268 claims across 25 drugs.

Francis Alenghat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Francis Alenghat as offering telehealth.

Dmand AI links 20 papers to Francis Alenghat, published from 2012 to 2021. 2021 was the busiest year, with 7. The most frequent topics are Heart Failure, Atherosclerosis and Cholesterol. Francis Alenghat has published most often in ESC Heart Fail. Francis Alenghat's most frequent co-authors are David Eric Golan, MD, PhD, Jonathan S. Grinstein and Ann Bich Nguyen, MD.

CMS Open Payments shows 35 general payments to Francis Alenghat from 11 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $227.

Francis Alenghat graduated from Harvard Medical School in 2005.